236 related articles for article (PubMed ID: 27531690)
1. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
[TBL] [Abstract][Full Text] [Related]
2. Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?
Rezaieyazdi Z; Sahebari M; Hatef MR; Abbasi B; Rafatpanah H; Afshari JT; Esmaily H
Lupus; 2011 Dec; 20(14):1494-500. PubMed ID: 21993388
[TBL] [Abstract][Full Text] [Related]
3. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
[TBL] [Abstract][Full Text] [Related]
4. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk.
Barnes EV; Narain S; Naranjo A; Shuster J; Segal MS; Sobel ES; Armstrong AE; Santiago BE; Reeves WH; Richards HB
Lupus; 2005; 14(8):576-82. PubMed ID: 16175928
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
7. Performance of cytokine models in predicting SLE activity.
Ruchakorn N; Ngamjanyaporn P; Suangtamai T; Kafaksom T; Polpanumas C; Petpisit V; Pisitkun T; Pisitkun P
Arthritis Res Ther; 2019 Dec; 21(1):287. PubMed ID: 31842967
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
9. Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients.
Tang Y; Tao H; Gong Y; Chen F; Li C; Yang X
J Interferon Cytokine Res; 2019 Jul; 39(7):410-415. PubMed ID: 31173544
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
12. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
13. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
15. Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity.
Xie HH; Shen H; Zhang L; Cui MY; Xia LP; Lu J
Sci Rep; 2018 Feb; 8(1):3462. PubMed ID: 29472590
[TBL] [Abstract][Full Text] [Related]
16. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
17. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
Liou LB
Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus.
Cigni A; Pileri PV; Faedda R; Gallo P; Sini A; Satta AE; Marras R; Carta E; Argiolas D; Rum I; Masala A
J Investig Med; 2014 Jun; 62(5):825-9. PubMed ID: 24987977
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]